|
Aug 27
|
GI Innovation and MSD partner for trial of GI-102 and Keytruda regimen for cancer
|
|
Aug 26
|
MSD snags European approval for pulmonary arterial hypertension therapy
|
|
Aug 26
|
Merck & Co., Inc. (MRK): A Good Undervalued Stock to Invest In Now
|
|
Aug 26
|
The Zacks Analyst Blog Costco, Merck & Co., Linde, Hamilton Beach Brands and Armanino Foods of Distinction
|
|
Aug 26
|
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, for the Treatment of PAH in Adult Patients With Functional Class II-III
|
|
Aug 24
|
With 78% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing
|
|
Aug 2
|
How To Earn $100 Per Month From Merck Stock
|
|
Aug 2
|
Results: Merck & Co., Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
|
|
Aug 1
|
IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer
|
|
Jul 31
|
Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023
|
|
Jul 31
|
Vertex’s pain drug gets speedy FDA review; Keytruda hits a sales milestone
|
|
Jul 31
|
Heard on the Street Tuesday Recap: Fed Purgatory
|
|
Jul 31
|
Q2 2024 Merck & Co Inc Earnings Call
|
|
Jul 30
|
Merck (MRK) Q2 2024 Earnings Call Transcript
|
|
Jul 30
|
Big movers: NVIDIA slumps; P&G, Merck down, PayPal up
|
|
Jul 30
|
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
|
|
Jul 30
|
Why this analyst is 'extremely bullish' on biopharma
|
|
Jul 30
|
Merck Stock Slides on Lowered Adjusted EPS Guidance
|
|
Jul 30
|
Merck (MRK) Q2 Earnings & Sales Beat Estimates, Cuts '24 EPS View
|
|
Jul 30
|
Stock Market Today: Stock Market News And Analysis
|